Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sinohealth Holdings Ltd. ( (HK:2361) ) has issued an update.
Sinohealth Holdings has clarified that its public float stood at 16.45% as of a recent announcement, below the 25% minimum required under Hong Kong listing rules, primarily because 8.84% of its share capital is held in a share award scheme and not counted as public float. The company plans to gradually grant these share awards over the next three years to non-core connected persons, using performance-based criteria to support long-term growth while bringing more shares into public hands.
To restore compliance, the company intends to boost its public float by at least 8 percentage points by the end of June 2027 through a mix of equity financing and potential sell-downs by major shareholders to independent investors. Sinohealth will begin actively engaging placing agents, major shareholders, and potential investors after its 2025 annual results, and will provide monthly updates on progress while it remains non-compliant with the listing rules, signaling a structured timeline and governance focus for stakeholders.
More about Sinohealth Holdings Ltd.
Sinohealth Holdings Limited is a company incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange under stock code 2361. The company operates within the healthcare-related sector and uses equity-based incentives, including a share award scheme, to attract and retain key personnel and align employee performance with its medium- to long-term strategic development.
Average Trading Volume: 12,990
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.17B
See more data about 2361 stock on TipRanks’ Stock Analysis page.